Wall Street analyst estimates for KORU Medical Systems, Inc. (KRMD): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-0.02 | ||
| 2026-08-05 | $0.01 | $-0.02 | +155.6% |
| 2026-05-06 | $-0.02 | $-0.02 | +0.0% |
| 2026-03-12 | $-0.01 | $-0.02 | +50.0% |
| 2025-11-12 | $-0.02 | $-0.03 | +33.3% |
| 2025-08-06 | $0.01 | $-0.03 | +133.3% |
| 2025-05-07 | $-0.03 | $-0.02 | -50.0% |
| 2025-03-12 | $-0.03 | $-0.03 | +0.0% |
Valuation Ratios
| Price / Book | 8.02 |
| EV / EBITDA | -140.34 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.3M | $16.0M | $17.4M | $23.2M | $24.2M | $23.5M | $27.9M | $28.5M | $33.6M | $41.1M |
| Cost of Revenue | $4.7M | $6.5M | $6.5M | $8.3M | $9.2M | $9.7M | $12.5M | $11.8M | $12.3M | $15.5M |
| Gross Profit | $7.6M | $9.5M | $10.8M | $14.9M | $14.9M | $13.8M | $15.4M | $16.7M | $21.3M | $25.6M |
| Research & Development | $237486 | $60704 | $241124 | $740475 | $1.3M | $2.5M | $5.0M | $5.7M | $5.3M | $4.4M |
| Selling, General & Admin | $7.8M | $7.9M | $8.2M | $9.8M | 0 | 0 | 0 | 0 | 0 | $23.4M |
| Operating Expenses | $8.3M | $8.0M | $8.7M | $10.9M | $16.2M | $20.8M | $26.1M | $27.0M | $27.8M | $28.6M |
| Operating Income | -$736251 | $1.5M | $1.2M | $585679 | -$1.3M | -$7.0M | -$10.8M | -$10.3M | -$6.4M | -$3.0M |
| EBITDA | -$474202 | $1.9M | $2.4M | $4.3M | $1.6M | -$5.9M | -$10.1M | -$8.9M | -$5.3M | -$1.8M |
| Interest Expense | $1886 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -$776699 | $1.6M | $1.2M | $696418 | -$1.2M | -$6.4M | -$10.7M | -$9.8M | -$6.1M | -$2.6M |
| Income Tax | -$241700 | $483075 | $266380 | $132069 | $17800 | -$1.8M | -$2.0M | $4.0M | $2893 | $21890 |
| Net Income | -$535000 | $1.1M | $910570 | $564349 | -$1.2M | -$4.6M | -$8.7M | -$13.7M | -$6.1M | -$2.6M |
| EPS | $-0.01 | $0.03 | $0.02 | $0.01 | $-0.03 | $-0.10 | $-0.19 | $-0.30 | $-0.13 | $-0.06 |
| EPS (Diluted) | $-0.01 | $0.03 | $0.02 | $0.01 | $-0.03 | $-0.10 | $-0.19 | $-0.30 | $-0.13 | $-0.06 |
| Shares Outstanding (Diluted) | $37.9M | $38.4M | $38.9M | $39.1M | $41.9M | $44.4M | $45.0M | $45.6M | $45.8M | $46.2M |
Price
| Price | $3.22 |
| Market Cap | $148M |
| Exchange | NASDAQ |
| Country | US |
Related companies: HIND · INFU · MXCT · NYXH · OSUR · PRE · PROF
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of KRMD: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks